Skip Navigation

Advertise|Press|Contact|FAQ|About Us

Bookmark/Print/Share

Home » Clinical Trials » Location » New Zealand

Christchurch, New Zealand Clinical Trials

Anemia

Canterbury District Health Board Updated

A clinical trial to evaluate treatments using Pacritinib and Best Available Therapy for patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis

Aneurysm

Christchurch Hospital, CDHB

Patients are needed to participate in a clinical research study of Vascutek Anaconda™ Stent Graft System to evaluate Abdominal Aortic Aneurysm

Arthritis and Arthritic Pain

The Canterbury Geriatric Medical Research Trust, c/- The Princess Margaret Hospital

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Arthritis, Rheumatoid

Asthma

Research Site Updated

A clinical research study of lebrikizumab and placebo for the treatment of Asthma

Atopic Dermatitis

Research Site

A clinical research study of dupilumab and placebo for the treatment of Atopic Dermatitis

Blood Cancer

Research Site

A clinical research study of Denosumab and Zoledronic acid

Bone Diseases

Research Site

A clinical research study of Denosumab and Zoledronic acid

Bone Metastases

Research Site

A clinical research study of Denosumab and Zoledronic acid

Bronchiectasis

Research Site

A clinical trial seeking patients for a research study for the treatment of Bronchiectasis

Cataracts

Research Site

Patients are needed to participate in a clinical research study of Denosumab and Placebo

Chronic Lymphocytic Leukemia

Research Site Updated

Patients are needed to participate in a clinical research study evaluating GDC-0199, Rituximab [MabThera/Rituxan] and Bendamustine for the treatment of Chronic Lymphocytic Leukemia

Cystic Fibrosis

Canterbury Respiratory Research Group

A Phase 3 clinical study for patients with Cystic Fibrosis

Dermatitis, Atopic

Research Site

A clinical research study of dupilumab and placebo for the treatment of Atopic Dermatitis

Diabetes Mellitus, Type 2

Research Site

A clinical research study of Placebo, Canagliflozin, 100 mg and Canagliflozin, 300 mg for the treatment of Diabetes Mellitus, Type 2 or Albuminuria

Research Site Updated

A Phase 3 clinical study for patients with Diabetes Mellitus, Type 2 or Diabetic Nephropathies

1218.149.06403 Boehringer Ingelheim Investigational Site Updated

Patients are needed to participate in a clinical research study evaluating placebo and Linagliptin for the treatment of Diabetes Mellitus, Type 2

Local Institution 3700

Patients are needed to participate in a clinical research study evaluating Exenatide Once Weekly and Placebo for the treatment of Type 2 Diabetes Mellitus

Local Institution 3715

Patients are needed to participate in a clinical research study evaluating Exenatide Once Weekly and Placebo for the treatment of Type 2 Diabetes Mellitus

View More »

Local Institution 3716

Patients are needed to participate in a clinical research study evaluating Exenatide Once Weekly and Placebo for the treatment of Type 2 Diabetes Mellitus

Dyslipidemia

Research Site

Patients are needed to participate in a clinical research study evaluating Evolocumab (AMG 145), Placebo and Effective statin therapy for the treatment of Dyslipidemia

Emphysema

Christchurch Hospital NZ

A clinical research study of Alpha1-proteinase inhibitor (human), modified process (Alpha-1 MP) and 0.9% Sodium Chloride for Injection, USP for the treatment of Pulmonary Emphysema in Alpha-1 PI Deficiency

Epilepsy

New Zealand, Canterbury

Patients are needed to participate in a clinical research study of USL261 and Placebo to evaluate Epilepsy

New Zealand, Canterbury

A clinical trial seeking patients for a research study for the treatment of Epilepsy

Heart Attack (Myocardial Infarction)

GSK Investigational Site

A Phase 3 clinical study for patients with Acute Coronary Syndrome

Lipid and Diabetes Research Group

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Southern Clinical Trials Riccarton

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Hemorrhage

1321.3.64004 Boehringer Ingelheim Investigational Site Updated

Patients are needed to participate in a clinical research study of idarucizumab to evaluate Hemorrhage

Hepatitis

Research Site

A clinical research study of SOF/GS-5816, SOF and RBV for the treatment of Hepatitis C Virus Infection

High Cholesterol (Hyperlipidemia)

Lipid and Diabetes Research Group

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Southern Clinical Trials Riccarton

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Inflammatory Bowel Disease

Canterbury Health Laboratories (Local Lab)

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Christchurch Hospital DR RICHARD GEARRY

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Influenza

GSK Investigational Site

A Phase 3 clinical study for patients with Influenza, Human

Kidney Disease

Research Site Updated

A Phase 3 clinical study for patients with Diabetes Mellitus, Type 2 or Diabetic Nephropathies

Leukemia

Research Site Updated

Patients are needed to participate in a clinical research study evaluating GDC-0199, Rituximab [MabThera/Rituxan] and Bendamustine for the treatment of Chronic Lymphocytic Leukemia

Christchurch Hospital

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Liver Metastases

Christchurch Hospital

A Phase 3 clinical study for patients with Colorectal Cancer Metastatic

Lung Cancer

Teva Investigational Site 79002 Updated

Patients are needed to participate in a clinical research study evaluating Custirsen + Docetaxel and Docetaxel for the treatment of Non-Small Cell Lung Cancer

Lymphoma

Research Site

Patients are needed to participate in a clinical research study evaluating BAY80-6946 for the treatment of Lymphoma, Non-Hodgkin

Malignant Melanoma

Research Site Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Melanoma

Research Site Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Mesothelioma

Canterbury Regional Cancer & Haematology Service Updated

A Phase 2 clinical study for patients with Malignant Pleural Mesothelioma

Multiple Myeloma

1601

Patients are needed to participate in a clinical research study of plitidepsin + dexamethasone and dexamethasone to evaluate Relapsed/Refractory Multiple Myeloma

Canterbury Health Laboratories

A Phase 3 clinical study for patients with Multiple Myeloma

Research Site

A clinical research study of Denosumab and Zoledronic acid

Myelofibrosis

Canterbury District Health Board Updated

A clinical trial to evaluate treatments using Pacritinib and Best Available Therapy for patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis

Neoplasm Metastasis

Research Site

A clinical research study of Denosumab and Zoledronic acid

Neoplasms

Research Site

A clinical trial to evaluate treatments for patients with Prostate Neoplasms

Research Site Updated

Patients are needed to participate in a clinical research study of ARN-509 and Placebo to evaluate Prostatic Neoplasms

Research Site

A clinical research study of Denosumab and Zoledronic acid

Nocturia

Site:NZ64001

Patients are needed to participate in a clinical research study of Solifenacin Succinate, Mirabegron and Placebo to evaluate Overactive Bladder, Urgency Incontinence, Urinary Bladder Overactive or Urinary Bladder Diseases\Urologic Diseases

Non-Hodgkin's Lymphoma

Research Site

Patients are needed to participate in a clinical research study evaluating BAY80-6946 for the treatment of Lymphoma, Non-Hodgkin

Non-Small Cell Lung Cancer

Site Reference ID/Investigator# 125610

Patients are needed to participate in a clinical research study of veliparib, carboplatin, paclitaxel and placebo to evaluate Squamous Non-Small Cell Lung Cancer

Teva Investigational Site 79002 Updated

Patients are needed to participate in a clinical research study evaluating Custirsen + Docetaxel and Docetaxel for the treatment of Non-Small Cell Lung Cancer

Osteopenia

Research Site

Patients are needed to participate in a clinical research study of Denosumab and Placebo

Osteoporosis

Research Site

A clinical trial seeking patients for a research study for the treatment of Postmenopausal Women With Osteoporosis

Research Site

Patients are needed to participate in a clinical research study of Denosumab and Placebo

Ovarian Cancer

Christchurch Hospital

A Phase 1/Phase 2 clinical study for patients with Ovarian Cancer

Pancreatic Cancer

Christchurch Hospital

A Phase 1 clinical study for patients with Pancreatic Cancer

Prostate Cancer

Research Site Updated

Patients are needed to participate in a clinical research study of ARN-509 and Placebo to evaluate Prostatic Neoplasms

Research Site

A clinical trial to evaluate treatments for patients with Prostate Neoplasms

Research Site

Patients are needed to participate in a clinical research study of Enzalutamide and Placebo to evaluate Nonmetastatic Castration-Resistant Prostate Cancer

Canterbury Urology Research Trust

A clinical trial to evaluate treatments for patients with Prostate Cancer, Metastatic Prostate Cancer or Castration-resistant Prostate Cancer

Research Site

Patients are needed to participate in a clinical research study of Denosumab and Placebo

Rheumatoid Arthritis

The Canterbury Geriatric Medical Research Trust, c/- The Princess Margaret Hospital

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Arthritis, Rheumatoid

Stroke

Lipid and Diabetes Research Group

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Southern Clinical Trials Riccarton

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Ulcerative Colitis

Canterbury Health Laboratories (Local Lab)

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Christchurch Hospital

A clinical research study of tofacitinib and Placebo for the treatment of Ulcerative Colitis

Christchurch Hospital

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Christchurch Hospital DR RICHARD GEARRY

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Site Reference ID/Investigator# 120837

A Phase 3 clinical study for patients with Ulcerative Colitis

Ulcers

Canterbury Health Laboratories (Local Lab)

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Christchurch Hospital

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Christchurch Hospital

A clinical research study of tofacitinib and Placebo for the treatment of Ulcerative Colitis

Christchurch Hospital DR RICHARD GEARRY

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Site Reference ID/Investigator# 120837

A Phase 3 clinical study for patients with Ulcerative Colitis

Urinary Incontinence

Site:NZ64001

Patients are needed to participate in a clinical research study of Solifenacin Succinate, Mirabegron and Placebo to evaluate Overactive Bladder, Urgency Incontinence, Urinary Bladder Overactive or Urinary Bladder Diseases\Urologic Diseases